Welcome TJ Stalvey
We are pleased to welcome our latest Imagioneer to the Imagion Bio team! As we grow confidence in the development of our business, we are adding imperative…
MagSense® HER2 Breast Cancer First-in-human Study Progress Update
Imagion Biosystems Limited (ASX: IBX) is pleased to provide an update on the progress of its first-in-human study for the MagSense® HER2 breast cancer imaging…
Imagion Biosystems 2021 Full Year Results
Imagion Biosystems has released its Annual Report for the year ended 31 December 2021. See linked documents below. 2021 Clinical Highlights: Multiple…
Quarterly Activity Report and Appendix 4C for 31 December 2021
Imagion has released the Quarterly Activity Report and Appendix 4C for the period ending on 31 December 2021. The announcement highlights a recap of the…
Imagion Bio at The Edison Open House: Global Healthcare 2022
Our CEO, Bob Proulx, connected with the Edison Group during their Global Healthcare Open House to discuss in detail, the nanotechnology behind our bio-imaging…
Application for quotation of +securities
The document "Application for quotation of +securities" was lodged with ASX on 6th January, 2022. Please click to review the full announcement at ASX.
Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
The document "Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001" was lodged with ASX on 6th January, 2022. Please click to review the full…
Biotech Daily — Dr Boreham's Crucible: Imagion Biosystems
Tim Boreham revisits Imagion Biosystems' potential in this 5-1/2 page article profiling the company and discussing its recent milestones. Read the article…
Notification of Issue, Conversion of Payment up of Unquoted Equity Securities
The document "Notification of Issue, Conversion of Payment up of Unquoted Equity +Securities" was lodged with ASX on 16 December, 2021. Please click to review…
Remuneration Update and Employee Equity Incentives
The document "Remuneration Update and Employee Equity Incentives" was lodged with ASX on 16 December 2021. Please click to review the full announcement at ASX.